US equities
|
META
$620.19
▼-1.64%
MU
$928.76
▲+2.77%
TSLA
$407.46
▲+4.04%
NVDA
$217.94
▲+0.90%
SPCX
$148.58
▲+1.14%
AAPL
$347.10
▲+0.93%
AMD
$560.26
▲+5.45%
MSFT
$531.33
▼-0.24%
META
$620.19
▼-1.64%
MU
$928.76
▲+2.77%
TSLA
$407.46
▲+4.04%
NVDA
$217.94
▲+0.90%
SPCX
$148.58
▲+1.14%
AAPL
$347.10
▲+0.93%
AMD
$560.26
▲+5.45%
MSFT
$531.33
▼-0.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
April 01, 2024
From
Eiger BioPharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
EIGR
Eiger BioPharmaceuticals Announces Leadership Change
December 15, 2022
From
Eiger BioPharmaceuticals, Inc.
Via
Business Wire
Tickers
EIGR
